Recurrent multicentric glioblastoma multiforme responds to thalidomide and chemotherapy

被引：0
|
作者：
Phuphanich, S [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Neurol Serv, Tampa, FL 33612 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Div Neurooncol, Tampa, FL USA
来源：
ONCOLOGY-NEW YORK | 2002年 / 16卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：276 / +
页数：2
相关论文
共 50 条
  • [31] Updates in the Management of Recurrent Glioblastoma Multiforme
    Prajapati, Hanuman Prasad
    Ansari, Ahmad
    [J]. JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY, 2023, 84 (02) : 174 - 187
  • [32] Glioblastoma multiforme: mechanisms of resistance to chemotherapy
    Rieger, J
    Roth, W
    Glaser, T
    Winter, S
    Rieger, L
    Dichgans, J
    Weller, M
    [J]. NEUROLOGY PSYCHIATRY AND BRAIN RESEARCH, 1999, 7 (01) : 37 - 46
  • [33] Low-dose Fotemustine as Second-line Chemotherapy for Recurrent Glioblastoma Multiforme
    De Felice, Francesca
    Bulzonetti, Nadia
    Musio, Daniela
    D'Elia, Alessandro
    Salvati, Maurizio
    Tombolini, Vincenzo
    [J]. ANTICANCER RESEARCH, 2013, 33 (09) : 4013 - 4016
  • [34] Efficacy of chemotherapy plus bevacizumab in recurrent multiforme glioblastoma: A real-life study
    Beige, A. V. A.
    Ghiringhelli, F.
    Vincent, J.
    Lecuelle, J.
    Truntzer, C.
    Farah, W.
    Borsotti, F.
    Mazilu, I.
    Ilie, S. M.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S523 - S523
  • [35] A phase II study of thalidomide and irinotecan for treatment of glioblastoma multiforme
    Camilo E. Fadul
    Linda S. Kingman
    Louise P. Meyer
    Bernard F. Cole
    Clifford J. Eskey
    C. Harker Rhodes
    David W. Roberts
    Herbert B. Newton
    J. Marc Pipas
    [J]. Journal of Neuro-Oncology, 2008, 90
  • [36] Lenalidomide as an Alternative to Thalidomide for Treatment of Recurrent Erythema Multiforme
    Drahy, Faustine
    Ingen-Housz-Oro, Saskia
    Grootenboer-Mignot, Sabine
    Wolkenstein, Pierre
    Chosidow, Olivier
    [J]. JAMA DERMATOLOGY, 2018, 154 (04) : 487 - 489
  • [37] A phase II study of thalidomide and irinotecan for treatment of glioblastoma multiforme
    Fadul, Camilo E.
    Kingman, Linda S.
    Meyer, Louise P.
    Cole, Bernard F.
    Eskey, Clifford J.
    Rhodes, C. Harker
    Roberts, David W.
    Newton, Herbert B.
    Pipas, J. Marc
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2008, 90 (02) : 229 - 235
  • [38] UNUSUAL CASE OF MULTICENTRIC GLIOBLASTOMA MULTIFORME WITH RECURRENCE IN THE OLFACTORY BULB
    Flowers, Alexandra
    Killory, Brendan
    [J]. NEURO-ONCOLOGY, 2013, 15 : 108 - 108
  • [39] MULTICENTRIC AND ISOLATED MULTIFOCAL GLIOBLASTOMA MULTIFORME SIMULATING METASTATIC DISEASE
    PRATHER, JL
    LONG, JM
    VANHEERTUM, RL
    HARDMAN, J
    [J]. BRITISH JOURNAL OF RADIOLOGY, 1975, 48 (565): : 10 - 15
  • [40] Prognostic implication of multicentric and multifocal disease in patients with glioblastoma multiforme
    Quan, AL
    Ross, JS
    Lee, SY
    Stevens, GHJ
    Peereboom, DM
    Vogelbaum, MA
    Toms, SA
    Barnett, GH
    Suh, JH
    [J]. NEURO-ONCOLOGY, 2004, 6 (04) : 328 - 329
12345